[PSTX] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[PSTX] Poseida Therapeutics, Inc.
Announcement Date
10-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 258.13%
YoY- 265.97%
Quarter Report
PSTX's Result
PSTX's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 20,013 10,343 9,921 116,306 2,700 1,435 31 7458.69%
PBT -27,456 -38,847 -33,026 70,661 -43,036 -58,057 1 -
Tax 4,681 1,359 292 252 1,491 1,096 -17,602 -
NP -27,456 -40,206 -33,318 70,409 -44,527 -59,153 1 -
Tax Rate - - - -0.36% - - 1,198,216.25% -
Total Cost 47,469 50,549 43,239 45,897 47,227 60,588 30 13663.17%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -137.19 -388.73 -335.85 60.54 -1,649.15 -4,122.16 4.70 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.32 -0.47 -0.39 0.92 -0.71 -0.95 0.02 -
EPS Diluted -0.32 -0.47 -0.39 0.92 -0.71 -0.95 0.02 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.